We are live on ! Find out more
FCE

Fiera Capital (Europe) Portfolio holdings

AUM $213M
1-Year Est. Return 42.35%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+42.35%
3 Year Est. Return
+41.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$110M
Cap. Flow
+$2.26M
Cap. Flow %
2.05%
Top 10 Hldgs %
77.06%
Holding
61
New
11
Increased
20
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
ITUB icon
Itaú Unibanco
ITUB
+$16.9M
2
ABEV icon
Ambev
ABEV
+$6.89M
3
JD icon
JD.com
JD
+$6.28M
4
FMX icon
Fomento Económico Mexicano
FMX
+$5.95M
5
TAL icon
TAL Education Group
TAL
+$5.1M

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$15.7M
2
GILD icon
Gilead Sciences
GILD
+$15.1M
3
CELG
Celgene Corp
CELG
+$12.1M
4
TMO icon
Thermo Fisher Scientific
TMO
+$11.3M
5
BAP icon
Credicorp
BAP
+$5.44M

Sector Composition

Rank Sector Weight
1 Financials 25.32%
2 Communication Services 24.92%
3 Consumer Staples 20.6%
4 Consumer Discretionary 9.69%
5 Healthcare 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CZZ
26
DELISTED
Cosan Limited
CZZ
$305K 0.28%
47,798
+20,525
+75% +$146K
LCI
27
DELISTED
Lannett Company, Inc.
LCI
$278K 0.25%
+1,021
New +$232K
TMO icon
28
Thermo Fisher Scientific
TMO
$222B
$272K 0.25%
2,020
-87,602
-98% -$11.3M
AMGN icon
29
Amgen
AMGN
$226B
$261K 0.24%
1,633
-6,818
-81% -$1.07M
AEGR
30
DELISTED
Aegerion Pharmaceuticals
AEGR
$252K 0.23%
9,641
– –
BMY icon
31
Bristol-Myers Squibb
BMY
$132B
$240K 0.22%
3,710
+1,954
+111% +$122K
VALE icon
32
Vale
VALE
$63.4B
$217K 0.2%
+38,411
New +$279K
CVS icon
33
CVS Health
CVS
$122B
$214K 0.19%
+2,068
New +$209K
MDVN
34
DELISTED
MEDIVATION, INC.
MDVN
$208K 0.19%
3,210
-11,514
-78% -$660K
IPXL
35
DELISTED
Impax Laboratories, Inc.
IPXL
$185K 0.17%
3,949
+2,523
+177% +$100K
ILMN icon
36
Illumina
ILMN
$29B
$176K 0.16%
975
-1,970
-67% -$371K
REGN icon
37
Regeneron Pharmaceuticals
REGN
$83.2B
$155K 0.14%
341
-1,228
-78% -$520K
BDX icon
38
Becton Dickinson
BDX
$48.9B
$151K 0.14%
1,076
+834
+345% +$117K
BSX icon
39
Boston Scientific
BSX
$73.1B
$136K 0.12%
+7,675
New +$121K
AMPH icon
40
Amphastar Pharmaceuticals
AMPH
$896M
$126K 0.11%
8,451
-113,125
-93% -$1.51M
ABT icon
41
Abbott
ABT
$188B
$109K 0.1%
2,339
-2,771
-54% -$127K
CELG
42
DELISTED
Celgene Corp
CELG
$105K 0.1%
908
-100,874
-99% -$12.1M
SYK icon
43
Stryker
SYK
$133B
$97K 0.09%
1,047
-168,215
-99% -$15.7M
EW icon
44
Edwards Lifesciences
EW
$53B
$93K 0.08%
+3,924
New +$88K
BIIB icon
45
Biogen
BIIB
$30.6B
$92K 0.08%
216
-448
-67% -$177K
CAH icon
46
Cardinal Health
CAH
$55.5B
$89K 0.08%
+981
New +$84.5K
INCY icon
47
Incyte
INCY
$24.6B
$79K 0.07%
857
-4,011
-82% -$332K
IQV icon
48
IQVIA
IQV
$39.8B
$65K 0.06%
973
+632
+185% +$39.8K
ABBV icon
49
AbbVie
ABBV
$438B
– –
-5,332
Closed -$349
BMRN icon
50
BioMarin Pharmaceuticals
BMRN
$13.3B
– –
-515,289
Closed -$6.93K
1
2
3

Similar funds

LWM
LBA Wealth Management Jacksonville, Florida $190M AUM 12.13% 1-Year Est. Return
KKAMG
Kernodle & Katon Asset Management Group Searcy, Arkansas $167M AUM 10.03% 1-Year Est. Return
MTIP
Magee Thomson Investment Partners San Diego, California $259M AUM 34.48% 1-Year Est. Return
IMIM
Irving Magee Investment Management Conshohocken, Pennsylvania $260M AUM 32.44% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return
PEI
Permira Europe III St. Peter Port, Guernsey $157M AUM
DCM
Dialectic Capital Management Norwalk, Connecticut $155M AUM 59.34% 1-Year Est. Return
ACM
Astenbeck Capital Management Southport, Connecticut $130M AUM 8.61% 1-Year Est. Return

Fiera Capital (Europe)'s Q1 2015 Portfolio in Review

As of Q1 2015, Fiera Capital (Europe) held 61 positions worth $110M, up 80,907% from $136K the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Fiera Capital (Europe)'s Q1 2015 filing shows 11 new, 20 increased, 16 reduced and 13 closed positions. Its largest new stake was Luxoft Holding, Inc.: 97,865 shares worth $5.06M. The largest sale was Stryker, an estimated $15.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 15% a quarter earlier, followed by Communication Services and Consumer Staples.

  • Fiera Capital (Europe)'s largest Q1 2015 buy was Luxoft Holding, Inc.: 97,865 shares worth $5.06M.
  • Fiera Capital (Europe) added most to Itaú Unibanco in Q1 2015, an estimated $16.9M increase.
  • Fiera Capital (Europe)'s biggest Q1 2015 reduction was Stryker, cutting an estimated $15.7M.
  • Fiera Capital (Europe) fully exited Insulet in Q1 2015, selling an estimated $21.5K.
  • Fiera Capital (Europe)'s ten largest holdings make up 77% of its $110M portfolio in Q1 2015.
  • Fiera Capital (Europe) opened 11 new positions and closed 13 in Q1 2015.
  • Fiera Capital (Europe)'s portfolio value rose 80,907% quarter-over-quarter to $110M.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2015, filed 12 May 2015.